AEZS Archives - Page 5 of 7 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: AAPL Update & More

Apple Inc. AAPL – Options

We once again found a way to leverage AAPL’s current uptrend to our advantage yesterday using the options chain. Just to refresh people’s memories, the idea we highlighted in our premarket report was to monitor Weekly Calls in the $130-132 range.

As AAPL pressed to a daily high of $133.13 we saw significant action in both the $131 and $132 Calls. The $131’s dipped as low as 3.60 before running to a subsequent high of 4.50, for an intraday move equaling 25%, and the $132’s made a nice spike from 3.10-3.88; also a 25% swing.

Pazoo, Inc. PZOO

We also want to mention the performance of PZOO which surged to a new high of .0204 yesterday. In the video charts we’ve published on PZOO over the past couple of trading days, we mentioned that the 200DMA of .0204 should act as key resistance, and that’s where yesterday’s intraday run topped out. From a morning low of .0177, it marked a 15% jump.

From our observed low of .0049 on April 6th, PZOO’s new high marked an overall increase of 316% We stated this week that we want to see the stock maintain support in the channel between .011-.014, and that remains true today.

Any way you slice it, PZOO has performed admirably in the month of April.

Netlist, inc. NLST

Hitting our scanner this morning is a stock that has been in a steady downtrend for quite some time, which is gapping up in the premarket on the heels of an early PR linking the company to LG Electronics.

NLST has spent the better part of the last three months bottoming out, and the stock just set a new 52-week low yesterday. This is exactly the type of play that we like to monitor, as it gets kicked up off of annual lows.

Other Notable Gainers From Yesterday’s Watchlist

We’d also like to highlight two other plays that appeared in yesterday’s premarket report that provided opportunities for our readers.

SYMX traded in a daily range from 1.65-2.10, an increase of 27%

CANF rose from a low of 2.61 to hit 3.57; an intraday move of 37%

Extended Watchlist:
AGEN, CLDN, AEZS, VSR, TSLA

Blue Horseshoe Stocks: ESPR Highlights & Much More

Yesterday, on a day when the market as a whole was faltering, we’re proud to say we managed to bring our readers several opportunities to gain in both stocks and options:

Esperion Therapeutics, Inc. ESPR- Options Ideas

ESPR turned out to be a great call for us in yesterday’s morning report. The stock itself made an impressive session-long move from a low of 82.69 up to 100.50 (+22%), resulting in some monstrous spikes for the options ideas we highlighted.

We raised a flag of interest on in-the-money Weekly Calls, and were rewarded with mega-spikes across the board:

$80 Calls – Trading Range: 4.00-20.00 Max Gain: 400%
$85 Calls – Trading Range: 2.15-14.50 Max Gain: 574%
$90 Calls – Trading Range: .70-14.50 Max Gain: 1400%
$95 Calls – Trading Range: .64-7.25 Max Gain: 1032%

Even the play we designated as a longer-term selection, the 04/17 $90 Calls, were immediately and significantly impacted, trading in a range from 3.50-14.50. That move was good for intraday gains of up to 314%

As far as our other options calls were concerned, we met with success there as well:

American Airlines Group Inc. AAL – For AAL, we zeroed in on the 04/02 $55 Calls which ended up trading up from .79, to as high as 1.11, marking a 40% intraday gain. Any other contracts that got pushed into the money would have also provided excellent opportunities for successful day-trades.

Apple, Inc. AAPL – On AAPL, we mentioned that we’d be watching the 04/02 $129 Calls and those made a healthy run from 1.25-1.80, for a chance at profit in excess of 44% on the day.

Other Standouts From Tuesday

There was significant excitement over the success of our options calls yesterday, but we still don’t want these other notable gainers from our watchlist to get lost in the shuffle:

Propanc Health Group Corp. PPCH – Trading Range: .0211-.03 – Max Gain: 42%

Microvision, Inc. MVIS – Trading Range: 3.07-3.55 – Max Gain: 16%

NovaBay Pharma, Inc. NBY – Trading Range: .56-.65 – Max Gain: 16%

Black Diamond, Inc. BDE – Trading Range: 8.45-9.84 – Max Gain: 16%

Side Note:

We are going to be sitting on the sidelines watching like hawks until we hear from Janet Yellen as the big FOMC meeting kicks off today. What she ultimately has to say will likely sway the markets one way or the other; we will wait to see which direction they’re going to go.

If the bull market remains intact, we’ll be looking to go long on SPY Calls. Should the direction be a downward one, we can entertain UVXY and/or VIX Calls. Remember: Whatever way it plays out, we’ll want to stay in-the-money with our strike prices.

Extended Watchlist:
VTSS, RTRX, ATNM, RXDX, AEZS, ZQK

Blue Horseshoe Stocks: Update on AEZS & More

AEterna Zentaris, Inc. AEZS

Our Monday morning report this week included AEZS as a potential bottom play which we did end up timing perfectly, seeing an 18% intraday move (.55-.65) during that session.

We also focused in on AEZS yesterday morning, mentioning that further opportunities appeared possible, and were rewarded for the second straight day. The stock traded in a range from .67-.79, which registered as another 18% intraday jump.

Yesterday’s high marked an overall increase of 43% and provided an excellent example of why the setting of new all-time lows in a given stock is a phenomenon that will draw our attention every time.

We’ll continue to monitor this play as the week progresses, but all in all, we consider it to be a success already, with the chances it has given us to make solid gains over a period of just two days.

Quick Update on TASER International, Inc. TASR

We wanted to update readers on another stock we’ve been monitoring over the last week- TASR has also provided a modest opportunity over the past couple of sessions. The stock bounced off of support at 20.79 on Monday, and yesterday managed to push its way to a high of 24.44, a notable 17.5% increase.

Extended Watchlist:
IDRA, MOLG, SQNM, ONVO,

Blue Horseshoe Stocks: AEZS Recap & More

AEterna Zentaris, Inc. AEZS

We called AEZS in yesterday morning’s newsletter as a potential bottom play to kick off the week, and our timing really couldn’t have been much better. After opening at .55, it would run to as much as .65; a solid intraday increase totaling 18%

Any time we can make a quick profit off of a stock coming off of its all-time lows we consider it a big success, and will continue to monitor this stock for further opportunities it may present with any continuing rebound action.

The turnaround came in conjunction with a PR notice that AEterna had signed a license and technology transfer agreement pertaining to the company’s “doxorubicin” anti-cancer compound with Sinopharm A-Think Pharmaceuticals, a division of China’s largest pharmaceutical company. >> Read PR

Energy XXI (EXXI) – Bottom Watch

Speaking of stocks trading at landmark low points, as an apparent result of the continued slide in oil prices in addition to a recent financial update that was poorly-received, EXXI has come down to find new 52-week lows.

We’re going to put this stock on bottom-watch, while noting that further losses for crude could actually cause it to continue pushing its lower boundary. That certainly seems to be the opinion of some analysts, but as ever, where others see lost ground, we see opportunity on the horizon.

Either way it shakes out, we could see a substantial recovery of the EXXI chart once oil prices begin to rebound, so we’ll tag it for our ongoing watchlist and monitor the situation moving forward.

Blue Horseshoe Stocks: ISR, Bottom Plays & More

IsoRay, Inc. ISR

We first began tracking ISR back in early October as a potential bottom play, and just a few sessions subsequent to our first mention, we would witness a low of 1.22 (10/16).

It took just a couple of weeks for us to ride ISR to a 66% gain as it ran to a high of 2.03 at the end of October. It consolidated down from that level, and for the past month or so the stock has been trading channel between 1.50-1.70.

ISR is catching our attention once again this morning, as we picked up on a new update over the press wire regarding the company’s Cesium-131 low-dose radiation therapy for brain cancer sufferers (Learn More About Cesium-131).

The Barrow Neurological Institute conducted studies with 27 patients with several variations of brain cancer, and the company is reporting that there was no recurrence of the disease on the treated sites in 26 out of the 27 candidates, where other treatments had failed. >> Read PR

We’re going to be interested to see how the stock picks up trading following the holiday week, especially with such an encouraging piece of news out in the premarket. So far, the ISR has gone as high as 2.08 in preliminary trading this morning. We could be looking at a dip-and-scenario once the session commences; to remain interested we’ll want to see support hold at a minimum of 1.89 as that would mark a 50% retrace from the current premarket range.

Potential Bottom Plays

AEterna Zentaris, Inc. AEZS absolutely fell off a cliff back in early November, following FDA denial of a New Drug Application AEZS had submitted. The stock has spent the intervening time bottoming out, and it is now trading at all-time lows. This is exactly the sort of situation that sends us into “vulture-mode”, where we’re on the lookout for any signs of recovery after a stock has been hammered down.

Frontline, Ltd. FRO is a stock that is in the process of coming off of a recent bottom, and is showing signs of life here in today’s premarket, currently trading in the mid-1.30’s.

Extended Watchlist:
JNUG, GRPN, AG, ONNN